Bausch & Lomb vs STAAR Surgical
BLCO and STAA side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BLCO and STAA compare
Bausch & Lomb is the larger company, worth 5.8 times as much as STAAR Surgical ($7.1B against $1.2B).
STAAR Surgical grew revenue faster over the last twelve months (51.3% versus 8.9% for Bausch & Lomb).
STAAR Surgical keeps more of each dollar of sales as profit, with a net margin of 1.1% compared with −3.2% at Bausch & Lomb.
STAAR Surgical scores higher on the StockData Score (10 against 8 for Bausch & Lomb), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BLCO | STAA |
|---|---|---|
| Size and price | ||
| Market cap | $7.1B | $1.2B |
| Share price | $20.00 | $24.54 |
| Change, 1 year | 29.3% | −7.7% |
| Change, 5 years | – | −78.8% |
| Beta (5Y) | 0.78 | 1.50 |
| Employees | 13K | 957 |
| StockData Score | ||
| Total score | 8 | 10 (better) |
| Valuation score | 4 (better) | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 0 | 2 (better) |
| Health score | 1 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 351× |
| P/S | 1.3× (better) | 3.6× |
| P/B | 1.1× (better) | 3.4× |
| EV/EBITDA | 16.2× (better) | 76.4× |
| P/FCF | 52.1× | – |
| FCF yield | 1.9% (better) | −0.55% |
| Fair value | $27.45 | $15.38 |
| Margin of safety | 27.1% (better) | −59.6% |
| Growth | ||
| Revenue growth (TTM) | 8.9% | 51.3% (better) |
| Revenue growth, 5Y average | 8.4% (better) | 7.9% |
| Profitability | ||
| Gross margin | – | 76.6% |
| Operating margin | 6.1% (better) | 4.0% |
| Net margin | −3.2% | 1.1% (better) |
| FCF margin | 2.6% (better) | −2.0% |
| Return on equity | −2.7% | 1.1% (better) |
| Return on invested capital | 2.3% | 4.2% (better) |
| Financial health | ||
| Debt / equity | 0.80 (better) | 0.00 |
| Net debt / EBITDA | 6.42 | – |
| Interest coverage | 0.8× | – |
| Current ratio | 1.55 | 4.66 (better) |
| Altman Z-score | 1.03 | 7.82 (better) |
| Piotroski F-score | 3 (better) | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 10.7% | 110% |
| Held by insiders | 0.81% | – |
| Insider net buying, 12 months | $29.8K | $62.8M (better) |
| Superinvestors holding | 4 | – |
| Short interest, % of float | 0.84% | – |
Go deeper
- BLCO stock overview
- BLCO income statement
- BLCO valuation and score
- STAA stock overview
- STAA income statement
- STAA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.